Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Textual)

v3.7.0.1
Equity (Details Textual)
 3 Months Ended
Jan. 31, 2012
shares
Mar. 31, 2017
USD ($)
employees
$ / shares
shares
Mar. 31, 2016
USD ($)
Common Stock [Member]      
Equity (Textual)      
Shares of common stock, Shares   1,341,357  
Proceeds from common stock issued | $   $ 2,000,000  
Common shares issued for cashless exercise of warrants   4,234  
Termination of employees | employees   4  
Restricted Stock [Member]      
Equity (Textual)      
Stock based compensation expense | $   $ 45,000 $ 100,000
Number of shares of restricted stock, vested   5,000  
Number of shares yet to issue of restricted stock, vested   148,408  
Warrants [Member]      
Equity (Textual)      
Common shares issued for cashless exercise of warrants   4,234  
Stock based compensation expense | $   $ 18,984 57,144
Fair value of stock options | $   $ 64,091  
Warrants exercised by warrant holders   9,364  
Stock Options [Member]      
Equity (Textual)      
Number of stock option granted   2,260,500  
Stock options, term   10 years  
Fair value of stock options | $   $ 2,149,845  
Fair value assumptions, expected life   6 years  
Fair value assumptions, expected dividend rate   0.00%  
Options to purchase common shares, cancelled   523,000  
Total option expense | $   $ 900,000 $ 800,000
Minimum [Member] | Stock Options [Member]      
Equity (Textual)      
Exercise price | $ / shares   $ 1.03  
Stock options, vesting period   1 year  
Fair value assumptions, expected discount rate   1.99%  
Fair value assumptions, expected volatility rate   80.27%  
Maximum [Member] | Stock Options [Member]      
Equity (Textual)      
Exercise price | $ / shares   $ 1.58  
Stock options, vesting period   4 years  
Fair value assumptions, expected discount rate   2.28%  
Fair value assumptions, expected volatility rate   81.74%  
Affiliated Entity [Member]      
Equity (Textual)      
Warrant to purchase of common stock 99,617    
Warrant expiration, description The term of the warrants were extended to February 11, 2022 from January 31, 2019.